Scopolamine

GPTKB entity

Statements (50)
Predicate Object
gptkbp:instanceOf alkaloid
muscarinic antagonist
anticholinergic drug
gptkbp:ATCCode A04AD01
gptkbp:boilingPoint not applicable (decomposes)
gptkbp:CASNumber 51-34-3
gptkbp:category gptkb:World_Health_Organization_essential_medicines
gptkbp:chemicalFormula C17H21NO4
gptkbp:contraindication gptkb:myasthenia_gravis
glaucoma
prostatic hypertrophy
gptkbp:discoveredBy gptkb:Albert_Ladenburg
gptkbp:discoveredIn 1880
gptkbp:eliminationHalfLife 8 hours
gptkbp:excretion renal
gptkbp:foundIn gptkb:Datura_stramonium
gptkb:Atropa_belladonna
gptkb:Hyoscyamus_niger
https://www.w3.org/2000/01/rdf-schema#label Scopolamine
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction muscarinic acetylcholine receptor antagonist
gptkbp:meltingPoint 59–61 °C
gptkbp:metabolism hepatic
gptkbp:molecularWeight 303.35 g/mol
gptkbp:otherName gptkb:hyoscine
gptkbp:pregnancyCategory C (US)
gptkbp:PubChem_CID CHEMBL651
5184
DB00747
gptkbp:risk_of_overdose delirium
coma
seizures
gptkbp:routeOfAdministration oral
transdermal
intravenous
gptkbp:sideEffect confusion
blurred vision
drowsiness
hallucinations
dry mouth
gptkbp:solubility soluble in water
gptkbp:UNII 577I1CFA9H
gptkbp:used_in treatment of irritable bowel syndrome
palliative care for reducing respiratory secretions
preanesthetic medication
gptkbp:usedFor motion sickness
postoperative nausea and vomiting
gptkbp:bfsParent gptkb:Burundanga
gptkb:Antiemetics
gptkbp:bfsLayer 6